Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11014923 Bicyclic heterocycles as FGFR4 inhibitors

Patent 11014923 was granted and assigned to Incyte on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ding-Quan Qian0

Wenqing Yao0

Liang Lu0

Liangxing Wu0

Date of Patent

May 25, 2021

0

Patent Application Number

169249050

Date Filed

July 9, 2020

0

Patent Citations

US Patent 10851105 Bicyclic heterocycles as FGFR4 inhibitors

US Patent 10016348 Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C

0

US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors

US Patent 10208024 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

US Patent 10213427 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

US Patent 10214528 Bicyclic heterocycles as FGFR4 inhibitors

0

US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors

...

Patent Citations Received

US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 12024517 Salts of an FGFR inhibitor

0

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same

US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same

US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors

US Patent 11591329 Bicyclic heterocycles as FGFR inhibitors

...

Patent Primary Examiner

Leslie A. Royds Draper

0

Patent abstract

The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11014923 Bicyclic heterocycles as FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool